CompletedPhase 4NCT00168987

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Charite University, Berlin, Germany
Principal Investigator
Matthias Pirlich, MD
Charite University Hospital, Dept. of Gastroenterology, Hepatology and Endocrinology
Intervention
oral nutritional supplement rich in eicosapentanoic acid(drug)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
2005 – 2007

Study locations (1)

Collaborators

Pfrimmer Nutricia GmbH, Erlangen , Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00168987 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials